All Drugs and Chemicals

Vaccines

Heptavalent Pneumococcal Conjugate Vaccine

Immunologic Factors

Immunization Schedule patients \<7 years.

Immunization Schedule patients \> or = to 7 years and \<11 years of age

Immunization Schedule patients \> or = to 11 years of age

* Time 0 months: Prevnar 13 #1, Hib #1
* Time 1 months: Pediarix #1
* Time 2 months: Prevnar 13 #2, Hib #2
* Time 3-4 months: Pediarix #2
* Time 4-6 months: Draw post vaccine titers
* Time 6-12 months: Administer Hepatitis #3 to patients not immunized prior to treatment for cancer, or with negative Hepatitis B titers after two immunizations.

Immunization Schedule patients <7 years.

* Time 0 months: Hib #1, Prevnar 13 #1, Hepatitis B #1
* Time 1 month: Td#1, IPV #1(inactivated polio virus vaccine), Hepatitis B #2
* Time 2-3 months: Prevnar 13 #2, Hib #2
* Time 3-6 months: Td #2, Draw post vaccine titers Time 6-12 months: Administer Hepatitis #3 to patients not immunized prior to treatment for cancer, or with negative Hepatitis B titers after two immunizations.

Immunization Schedule patients > or = to 7 years and <11 years of age

* Time 0 month: Hib#1, Prevnar 13#1, Hepatitis B #1
* Time 1 month: Tdap(BOOSTRIX), Hepatitis B #2
* Time 2-3 months: Hib #2, Prevnar 13#2, Menactra
* Time 3-6 months: IPV, Draw post vaccine titers
* Time 6-12 months: Gardasil (dose #2 given 2 months after first dose, and dose #3 given 6 months after first dose)

Immunization Schedule patients > or = to 11 years of age

Nancy Kernan, MD

This study will look at your body's response to the new immunizations. We want to see how well they will protect you. Immunization is the same as vaccination. Our goal is to protect you as much as we can. We do not want you to have the measles, mumps, or whooping cough. We are doing the study because there is no standard way to re-immunize people after cancer treatments.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Prospective Trial of Vaccine Responses in Childhood Cancer Survivors	NCT00505063	Childhood Cance... Multiple Diseas...	Immunization Sc... Immunization Sc... Immunization Sc...	2 Years - 18 Years	Memorial Sloan Kettering Cancer Center
Prospective Trial of Vaccine Responses in Childhood Cancer Survivors	NCT00505063	Childhood Cance... Multiple Diseas...	Immunization Sc... Immunization Sc... Immunization Sc...	2 Years - 18 Years	Memorial Sloan Kettering Cancer Center

Spots Global Cancer Trial Database for immunization schedule patients > or = to 11 years of age